Loss Of Response Of Anti TNF-Α Agents As The Second-Line Therapy In Inflammatory Bowel Disease: Based On Korean National Insurnance Claims Data
Ha, J, Jang, EJ, Sohn, HSVolume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.1411
Date:
October, 2017
File:
PDF, 60 KB
english, 2017